Epizyme Inc (EPZM)
Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 33,341 |
| Receivables | 1,873 |
| TOTAL | $35,422 |
| Non-Current Assets | |
| PPE Net | 1,577 |
| Other Non-Current Assets | 361 |
| TOTAL | $1,938 |
| Total Assets | $37,360 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 2,498 |
| Accrued Expenses | 1,700 |
| TOTAL | $11,348 |
| Non-Current Liabilities | |
| Deferred Revenues | 7,150 |
| Other Non-Current Liabilities | 53,747 |
| TOTAL | $76,656 |
| Total Liabilities | $88,004 |
| Shareholders' Equity | |
| Retained earnings | -51,895 |
| TOTAL | $-50,644 |
| Total Liabilities And Equity | $37,360 |